Carrie Elyse Bearden | |
|---|---|
| Nationality | American |
| Occupation(s) | Psychologist and academic |
| Awards | 33rd H.W. Magoun Annual Distinguished Lectureship, Brain Research Institute, UCLA (2022) Fellow of the Association for Psychological Science (2019) Joel Elkes Research Award, American College of Neuropsychopharmacology (2017) A.E. Bennett Neuropsychiatric Research Award for Clinical Science, Society of Biological Psychiatry (2002) |
| Academic background | |
| Alma mater | UC Berkeley University of Pennsylvania |
| Thesis | The Neurocognitive Phenotype of 22q11.2 Deletion Syndrome |
| Doctoral advisor | Tyrone D. Cannon |
| Academic work | |
| Institutions | University of California, Los Angeles |
Carrie Elyse Bearden is an American psychologist and academic. She is a professor at the David Geffen School of Medicine, University of California, Los Angeles,[1] and Director of the UCLA Center for the Assessment and Prevention of Prodromal States, a clinical research program for youth at high risk for psychotic disorders.[2] She is most known for her research taking a ‘genetics first’ approach to study brain mechanisms underlying the development of serious mental illness. Her work has identified biological convergence between genetically and clinically defined high-risk populations.[3]